Supersapiens has announced a US$13.5 million capital raise led by MICA Ventures AG. The new energy management ecosystem, powered by Abbott’s Libre Sense Glucose Sport Biosensor, has secured ‘the largest investment in the sports continuous glucose monitoring (CGM) space.’
The company garnered investment from fitness and performance brands including the founder of Zwift, Eric Min, as well as the participation of Wahoo Fitness.
The lead investor Michael Hartweg is founder of MICA Ventures AG. He is joined by:
- Ed Baker, former VP of product and growth at Uber and head of international growth at Facebook;
- Harvey Schwartz, former co-president and CFO of Goldman Sachs;
- Rémi Duchemin, co-founder of OC Sport; and
- Eric Min, founder and CEO of Zwift.
Supersapiens also attracted global investment from CM Ventures, Rubix Ventures, Swiss Startup Group, and Wahoo Fitness.
“Sports continuous glucose monitoring (CGM) is an absolute game changer for all athletes. This is the beginning of a massive performance revolution,” said Hartweg, founder of MICA Ventures AG.
‘The Supersapiens ecosystem, powered by Abbott Libre Sense, empowers athletes to optimize fuelling, maximize training time, and can help increase performance gains. Its data interpretation tools represent the future of fuelling and sports performance.’
“I have been using glucose as a proxy for performance for the past 33 years,” said Phil Southerland, founder and CEO of Supersapiens. “As an athlete, I am intimately aware of the impact glucose has on the ability to achieve your goals.
“It gives me a great sense of pride to now bring this knowledge to the world, as there is no better tool for visualizing your training and recovery than sport CGM (continuous glucose monitoring). With a global backing from industry moguls and visionaries like Eric Min, we’re turning Supersapiens into a key system that no athlete will train without.”
Supersapiens’ partnership with global healthcare leader, Abbott, makes it the only energy management ecosystem that directly integrates with a Bluetooth-enabled CGM for sports – the Abbott Libre Sense Glucose Sport Biosensor.
This strategic partnership allows Supersapiens to scale quickly and, more importantly, offers athletes access to meaningful glucose data – minute-by-minute fuel levels live-streamed directly to their personalized device.
In its first 12 weeks on the market, Supersapiens has reported more than 2,000 paying athletes on its system, positioning them as a global leader in energy management for sports.
Supersapiens is working on its first hardware product, a wrist wearable called the Supersapiens Reader Version Zero. This will allow athletes to see their live-streaming fuel data with a quick glance.
‘The device will allow athletes using it to become the first to build a full training and coaching ecosystem around CGM for sports performance.’
“Once athletes have minute-by-minute fuel data right during a workout, they can quickly identify the correlation between their glucose levels and performance — translating more fuelled training minutes into bigger performance gains,” said Todd Furneaux, Supersapiens Co-founder and President.
The Supersapiens ecosystem powered by Abbott’s Libre Sense is now available in Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland, and the United Kingdom. For markets where Supersapiens has yet to be released, athletes can secure their spot on a waitlist.
